Patient Engagement – Envision Pharma Group

News and views:

Patient Engagement

New

Envision Pharma Group (Envision) has appointed James “Jim” Streeter to the role of President of Technology, CTO and member of the Executive Leadership Team.

Executive Leadership

Mar. 21, 2023

Envision Pharma Group acquires artificial intelligence technology company OKRA.ai

AI, Market Access, Medical, Technology

Feb. 07, 2023

Paul Archer promoted to Chief Commercial Strategy Officer

Executive Leadership

Feb. 18, 2022

GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth

GHO, Medical, Riparian, Strategic Consulting, Technology, Two Labs

Nov. 21, 2021

Two Labs, an Envision Pharma Group company acquires Riparian

Market Access, Pricing, Revenue Management, Riparian, Technology, Two Labs

Jul. 17, 2021

Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering

Commercialization, Compliance, Launch, Market Access, Strategic Consulting, Two Labs

Nov. 12, 2020

90TEN acquired by Envision Pharma Group

Medical, Patient Engagement, PR, Strategic Consulting

Apr. 08, 2020